WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...

The company's "next-generation" COVID-19 vaccine, mNexspike, was approved for adults 65 and older and younger people at risk ...

Bloomberg reported that the FDA recently granted Moderna Inc. (NASDAQ:MRNA) a narrower approval for its next-generation COVID ...